While other existing biomarkers of AKI (e.g., KIM-1, L-FABP) are associated with excessive ROS and hypoxia, respectively, and are acute markers of tissue injury (72, 73), they are not known to mediate further damage. The gene discussed is FABP1; the disease is acute kidney injury.